23h
Pharmaceutical Technology on MSNKeymed’s Stapokibart approved by NMPA for seasonal allergic rhinitisChina's National Medical Products Administration (NMPA) has approved Keymed Biosciences’ supplemental new drug application ...
Prevention on MSN11d
7 Ways to Stop Post-Nasal Drip, According to DoctorsAnother natural method that may help you find relief from environmental factors behind your post-nasal drip is by inhaling ...
Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to ...
Learn how allergies and other conditions can cause a sore throat, and how to identify the right treatment based on your ...
As Ozempic use rises, some patients report unexpected nasal symptoms, prompting researchers to investigate this new and unusual side effect.
The NHS will now offer immunotherapy pill Acarizax so the body can become less sensitive to dust mites over time and halt ...
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.
Should you start taking your allergy medicine now? We VERIFY the answer to that and other common questions about allergy treatments.
Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
The approval is based on a multi-center, randomized, double-blind, placebo-controlled phase III study to confirm the efficacy and safety of Stapokibart injection in treatment of adult patients with ...
The growing incidence of asthma, COPD, and allergies has created a sustained ... the effectiveness of generic inhalation and nasal drugs, focusing on improved drug delivery mechanisms and particle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results